Advance Analytical Technologies, Inc. has signed an agreement with US army Edgewood Chemical Biological Center (ECBC) at Aberdeen Proving Ground and Battelle Memorial Institute. The joint Cooperative Research and Development Agreement (CRADA) is focused on the potential application of Advanced Analytical technology to effectively detect bioterrorism agents.

Advanced Analytical Technology has expertise in enumerating and detecting individual microbial cells as well as being able to identify specific microbial species. The threat of bioterrorism is a reality and the US government continues to fund development of interesting technologies to address this threat.

According to Ms. Laurie Fazekas-Carey of the ECBC, " This agreement is a milestone in the multi-year relationship with Advanced Analytical and their RBD 3000 technology platform. ECBC has been working with the technology for over two years and is looking forward to exploring ways that it can be expanded to further our mission to detect chemical and biological agents."

Battelle is a world-wide leader in directed research and development for both government entities as well as for private industry. " This agreement is very consistent with our charter as well as our expertise. The project has a potential to meaningfully improve our national security and we are pleased to be a participant", said Ms. Lauren McNew, project manager at Battelle.

Because of the fundamental opportunity this brings Advanced Analytical, Dr Steven Lasky, President and CEO, has initiated the scientific research to support this endeavor. " ECBC has been a customer for years and we are looking forward to collaborating with them in applying our technology to a portable detection platform."